Jecko Thachil/LinkedIn
Mar 9, 2026, 14:10
Jecko Thachil: The Journey of Protamine – From Heparin Reversal to Potential Gene Therapy Applications
Jecko Thachil, Consultant Haematologist at NHS, shared a post on LinkedIn about his recent article, adding:
“Protamine is a very useful drug in reversing heparin and has been used for several years.
How did its journey start from the discovery of DNA and now may be relevant for gene therapy?”
Title: Protamine—The Journey from DNA to Heparin Neutralization to Gene therapy
Author: Jecko Thachil
Read the Full Article on Seminars in Thrombosis and Hemostasis

Other posts featuring Jecko Thachil on Hemostasis Today.
-
Nov 15, 2026, 09:41Girishkumar Modi: Navigating the 2026 Jehovah’s Witness Transfusion Policy Shift in Clinical Practice
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia
-
Nov 14, 2026, 23:44Paul Healy: EU Approves Frehemgo for Haemophilia A
-
Nov 14, 2026, 23:43Mehak Trehan: ASH 2026 Benign Hematology – Ten Abstracts Through an Indian Lens
-
Nov 14, 2026, 23:33Felipe Magalhaes Furtado: Artificial Intelligence Advances PNH Clone Detection Through Machine Learning